Biohit Oyj
Biohit Oyj B-shares Subscribed with Stock Options II 2013
DGAP-News: Biohit Oyj 12.12.2014 / 08:30 --------------------------------------------------------------------- Biohit Oyj Stock Exchange Release December 12, 2014 at 9:30 a.m. local time (EET) A total number of 55,000 new Biohit Oyj B-shares have been subscribed for with stock options II 2013 during November 5th, 2014 and November 13th, 2014. These shares have been entered into the trade register on December 12, 2014, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading is expected to begin on NASDAQ OMX Helsinki as of December 15, 2014 together with the existing B-shares. The share subscription price was EUR 2.2766 per share (40,000 shares Nov 5th) and EUR 3,00 (15,000 shares Nov 13th) respectively. The entire subscription price of EUR 136,064 will be credited to the reserve for invested non-restricted equity, and the company share capital remains unchanged. The shares have no nominal value. After the subscription the number of all Biohit Oyj's shares will rise into 14,135,593 shares (14,080,593) and B-shares will rise into 11,160,093 shares (11,105,093). The new shares will correspond to a percentage of 0.4% of Biohit Oyj's total number of shares and 0.08% of the voting rights after registration. The share subscription period with stock options II 2013 began on July 1, 2013 and will end June 30, 2015. The option schemes are based on the Biohit Oyj board resolution of June 19, 2013 and the Annual General Meeting authorization of April 13, 2011. The terms and conditions of the option schemes with additional information are available on Biohit Oyj website at www.biohithealthcare.com. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is 'Innovating for Health' - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com News Source: NASDAQ OMX --------------------------------------------------------------------- 12.12.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Biohit Oyj Finland ISIN: FI0009005482 End of News DGAP News-Service --------------------------------------------------------------------- 304899 12.12.2014
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden